Drugs

Cyclo-Oxygenase-2 and its Inhibition in Cancer: Is There a Role?
pp. 821-845(25)
Authors: Liao, Zhongxing; Mason, Kathryn A.; Milas, Luka

Therapeutic Potential of Vasopressin Receptor Antagonists
pp. 847-858(12)
Authors: Ali, Farhan; Guglin, Maya; Vaitkevicius, Peter; Ghali, Jalal K.

Satraplatin in Hormone-Refractory Prostate Cancer and Other Tumour Types: Pharmacological Properties and Clinical Evaluation
pp. 859-869(11)
Author: McKeage, Mark J.

Management of Hepatitis C Infection after Liver Transplantation
pp. 871-885(15)
Authors: Alsatie, Mazen; Chalasani, Naga; Kwo, Paul Y.

Montelukast in the Treatment of Allergic Rhinitis: An Evidence-Based Review
pp. 887-901(15)
Authors: Nayak, Anjuli; Langdon, Ronald B.

Aerosolised Antibacterials for the Prevention and Treatment of Hospital-Acquired Pneumonia
pp. 903-914(12)
Authors: Wood, G. Christopher; Swanson, Joseph M.

Pharmacological Treatments for Basal Cell Carcinoma
pp. 915-934(20)
Authors: Lee, Seongmu; Selva, Dinesh; Huilgol, Shyamala C.; Goldberg, Robert A.; Leibovitch, Igal

Exenatide: A Review of Its Use in Patients with Type 2 Diabetes Mellitus (as an Adjunct to Metformin and/or a Sulfonylurea)
pp. 935-954(20)
Authors: Cvetković, Risto S.; Plosker, Greg L.